Explore how multi-omics integration and molecular research are revolutionizing ovarian cancer detection and treatment through advanced genomic analysis.
Discover how repetitive noncoding RNA, once considered 'junk DNA,' is revolutionizing our understanding of high-grade serous ovarian cancer and opening new therapeutic possibilities.
Exploring the connection between P16INK4a promoter methylation and ovarian cancer through meta-analysis findings and clinical implications.
Exploring how RASSF1A promoter methylation drives ovarian cancer progression and its potential as a diagnostic biomarker.